IXAZOMIB CITRATE

UNII:	46CWK97Z3K
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₀H₂₃BCl₂N₂O₉
Preferred Substance Name:	IXAZOMIB CITRATE
InChIKey:	MBOMYENWWXQSNW-AWEZNQCLSA-N
GSRS Full Record:	46CWK97Z3K i

1239908-20-3
(R)-2,2′-(2-(1-(2-(2,5-Dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid
1,3,2-Dioxaborolane-4,4-diacetic acid, 2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-
2,2'-(2-((1R)-1-((N-(2,5-Dichlorobenzoyl)glycyl)amino)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid
2-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diacetic acid
Ixazomib citrate
Ixazomib citrate [JAN]
Ixazomib citrate [MI]
Ixazomib citrate [ORANGE BOOK]
Ixazomib citrate [USAN]
Ixazomib citrate [WHO-DD]
MLN-9708
MLN9708
NINLARO

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

IXAZOMIB CITRATE

Synonyms and Mappings

Resources